Latest Insider Transactions at Molina Healthcare, Inc. (MOH)
This section provides a real-time view of insider transactions for Molina Healthcare, Inc. (MOH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MOLINA HEALTHCARE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MOLINA HEALTHCARE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,067
-7.06%
|
$331,837
$311.88 P/Share
|
|
Mar 01
2022
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,370
+18.61%
|
$1,048,070
$311.88 P/Share
|
|
Mar 01
2022
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,990
-6.72%
|
$3,728,890
$311.88 P/Share
|
|
Mar 01
2022
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,869
+9.87%
|
$6,490,259
$311.88 P/Share
|
|
Mar 01
2022
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
72,861
-12.92%
|
$22,659,771
$311.88 P/Share
|
|
Mar 01
2022
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
131,956
+17.35%
|
$41,038,316
$311.88 P/Share
|
|
Mar 01
2022
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,548
-6.64%
|
$2,658,428
$311.88 P/Share
|
|
Mar 01
2022
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,510
+13.62%
|
$6,689,610
$311.88 P/Share
|
|
Mar 01
2022
|
Marc Russo EVP, Health Plans |
SELL
Payment of exercise price or tax liability
|
Direct |
626
-3.16%
|
$194,686
$311.88 P/Share
|
|
Mar 01
2022
|
Marc Russo EVP, Health Plans |
BUY
Grant, award, or other acquisition
|
Direct |
3,527
+15.11%
|
$1,096,897
$311.88 P/Share
|
|
Feb 23
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
105
-0.62%
|
$32,235
$307.97 P/Share
|
|
Feb 22
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
195
-1.13%
|
$61,035
$313.21 P/Share
|
|
Jan 10
2022
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,325
-3.66%
|
$382,925
$289.7 P/Share
|
|
Jan 01
2022
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
173
+1.0%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+1.15%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+1.79%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
173
+0.82%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+4.52%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
173
+3.39%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+3.91%
|
$55,014
$318.08 P/Share
|
|
Jan 01
2022
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
173
+19.39%
|
$55,014
$318.08 P/Share
|
|
Nov 15
2021
|
Daniel Cooperman Director |
SELL
Open market or private sale
|
Direct |
5,000
-55.06%
|
$1,545,000
$309.13 P/Share
|
|
Nov 15
2021
|
Daniel Cooperman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+35.51%
|
$165,000
$33.02 P/Share
|
|
Nov 08
2021
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
300
-1.73%
|
$91,500
$305.01 P/Share
|
|
Oct 01
2021
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
102
-1.99%
|
$27,642
$271.51 P/Share
|
|
Oct 01
2021
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
203
+4.74%
|
$55,013
$271.51 P/Share
|
|
Oct 01
2021
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
203
+5.51%
|
$55,013
$271.51 P/Share
|
|
Oct 01
2021
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
203
+1.16%
|
$55,013
$271.51 P/Share
|
|
Oct 01
2021
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
203
+0.97%
|
$55,013
$271.51 P/Share
|
|
Oct 01
2021
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
203
+1.37%
|
$55,013
$271.51 P/Share
|
|
Oct 01
2021
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
203
+27.1%
|
$55,013
$271.51 P/Share
|
|
Oct 01
2021
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
203
+2.14%
|
$55,013
$271.51 P/Share
|
|
Oct 01
2021
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
203
+4.1%
|
$55,013
$271.51 P/Share
|
|
Aug 09
2021
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
300
-1.72%
|
$79,500
$265.16 P/Share
|
|
Aug 03
2021
|
Dale B Wolf Director |
SELL
Open market or private sale
|
Direct |
2,500
-21.57%
|
$692,500
$277.19 P/Share
|
|
Aug 03
2021
|
Dale B Wolf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+17.74%
|
$82,500
$33.02 P/Share
|
|
Jul 01
2021
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
215
+1.03%
|
$55,040
$256.05 P/Share
|
|
Jul 01
2021
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
215
+1.22%
|
$55,040
$256.05 P/Share
|
|
Jul 01
2021
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+5.25%
|
$55,040
$256.05 P/Share
|
|
Jul 01
2021
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+1.47%
|
$55,040
$256.05 P/Share
|
|
Jul 01
2021
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
215
+4.51%
|
$55,040
$256.05 P/Share
|
|
Jul 01
2021
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+6.16%
|
$55,040
$256.05 P/Share
|
|
Jul 01
2021
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+2.31%
|
$55,040
$256.05 P/Share
|
|
Jul 01
2021
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
215
+38.53%
|
$55,040
$256.05 P/Share
|
|
Jun 30
2021
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117
+0.15%
|
$24,804
$212.68 P/Share
|
|
Jun 30
2021
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117
+0.23%
|
$24,804
$212.68 P/Share
|
|
Jun 10
2021
|
Dale B Wolf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+21.97%
|
$82,500
$33.02 P/Share
|
|
May 24
2021
|
Thomas L Tran |
SELL
Payment of exercise price or tax liability
|
Direct |
1,245
-4.01%
|
$316,230
$254.0 P/Share
|
|
May 20
2021
|
Thomas L Tran |
SELL
Open market or private sale
|
Direct |
3,196
-9.34%
|
$824,568
$258.03 P/Share
|
|
May 14
2021
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
777
-1.54%
|
$202,020
$260.48 P/Share
|